Viventia Bio Withdrawn, Nasdaq: VITA

Developing novel antibody drug conjugates for bladder and other cancers.

Industry: Health Care

Latest Trade: ()

First Day Return:

Return from IPO:

Industry: Health Care

Developing novel antibody drug conjugates for bladder and other cancers.
more less
IPO News for Viventia Bio
more
IPO Data
IPO File Date 10/21/2015
Offer Price
Price Range n/a
Offer Shares (mm) n/a
Deal Size ($mm) $86
IPO Data
IPO Date
Offer Price
Price Range n/a
Offer Shares (mm) n/a
Deal Size ($mm) $86
Underwriters
more
Company Data
Headquarters Winnipeg, Canada
Founded 1995
Employees 26
Website www.viventia.com